TABLE 1

Summary of Results

ParameterBaseline (n = 10)Repeat baseline (n = 10)50 mm Hg (n = 10)55 mm Hg (n = 9)60 mm Hg (n = 9)Repeat 60 mm Hg (n = 8)Adenosine (n = 10)P value determined by ANOVA*
PETco2 (mm Hg)38.9 ± 2.4N/A49.9 ± 0.154.8 ± 0.359.4 ± 1.259.7 ± 0.5N/A<0.0001
HR (beats/min)57 ± 859 ± 862 ± 766 ± 968 ± 1069 ± 876 ± 10<0.001
f (breaths/min)12 ± 4N/A17 ± 519 ± 422 ± 523 ± 6N/A<0.001
SBP (mm Hg)109 ± 13117 ± 13119 ± 15123 ± 11131 ± 12125 ± 8121 ± 13<0.001
DBP (mm Hg)65 ± 1171 ± 1168 ± 1270 ± 1074 ± 1371 ± 770 ± 120.196
RPP (bpm × mm Hg)6,135 ± 1,6506,900 ± 1,1657,140 ± 1,4957,487 ± 1,5038,256 ± 1,4937,666 ± 1,2409,123 ± 1,6320.001
MBF (mL/min/g)0.45 ± 0.080.52 ± 0.100.62 ± 0.200.76 ± 0.210.86 ± 0.240.89 ± 0.242.00 ± 0.34<0.0001
Corrected MBF (mL/min/g)0.44 ± 0.0450.47 ± 0.090.51 ± 0.150.57 ± 0.080.59 ± 0.150.64 ± 0.191.37 ± 0.31<0.0001
MFR1.37 ± 0.3171.68 ± 0.331.97 ± 0.452.12 ± 0.484.53 ± 0.70<0.0001
  • * Three participants for whom data were missing were excluded from repeated-measures ANOVA.

  • n = number of participants; N/A = not available.

  • Values (other than P values) are presented as mean ± SD.